Long-Term Analysis of Phase II Studies of Single-Agent Lenalidomide in Relapsed/Refractory Mantle Cell Lymphoma
American Journal of Hematology - United States
doi 10.1002/ajh.24854
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 28, 2017
Authors
Publisher
Wiley